×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
AGC partners with Medigene - BioProcess Insider
BioProcess International
CDMO AGC Biologics, has agreed to support Medigene with their IND filing and clinical trials to treat cancer.
1 month ago
Medigene to Present at Upcoming Scientific Conferences
Yahoo Finanza
Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and...
1 week ago
AGC Biologics Inks TCR-T Cell Services Agreement with Medigene
Contract Pharma
AGC Biologics Inks TCR-T Cell Services Agreement with Medigene. AGC will provide autologous production for a next-generation-therapy product...
6 months ago
Medigene AG (MDGEF) Full Year 2023 Earnings Call Transcript
Seeking Alpha
Medigene AG (OTCPK:MDGEF) Full Year 2023 Earnings Conference Call March 28, 2024 10:00 AM ETCompany ParticipantsPamela Keck – Head-Investor...
1 month ago
AGC Biologics Signs TCR-T Cell Services Agreement to Support Medigene's New Cell Therapy Product
Business Wire
AGC Biologics is providing autologous clinical production for Medgine's therapy product focused on the treatment of solid cancers.
6 months ago
Medigene AG expands patent portfolio in Japan for iM-TCR Technology
BioSpectrum Asia
iM-TCR technology controls mechanism to regulate the efficacy and safety of its T cell receptor engineered T cell (TCR-T) therapies.
1 month ago
Cell therapy weekly: Positive Phase I/II data of HIV gene therapy
RegMedNet
This week: AGC Biologics (WA, USA) signed a service agreement to support the production of Medigene's (Planegg, Germany) TCR-T cell therapy...
5 months ago
BioNTech jumps into PRAME game, paying Medigene $29M for preclinical T-cell therapy program
Fierce Biotech
BioNTech jumps into PRAME game, paying Medigene $29M for preclinical T-cell therapy program ... BioNTech, flush with COVID-19 cash, has struck...
26 months ago
BioNTech and Medigene Link Up for Solid Tumor T-Cell Treatments
BioSpace
BioNTech and Medigene announced a global agreement to develop T-cell immunotherapies against cancer. The three-year collaboration will focus...
26 months ago
Medigene appoints Pamela Keck as head of IR and corporate communications
IR Magazine
Medigene, the German biotech focused on immunotherapy to treat cancer, has named Pamela Keck as its vice president and head of.
14 months ago